Defects in mucosal immunity leading to ulcerative colitis.
about
High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous diseaseThe effect of smoking on intestinal inflammation: what can be learned from animal models?Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel diseaseThe gut microbiota shapes intestinal immune responses during health and diseaseInflammatory bowel diseaseCD209 in inflammatory bowel disease: a case-control study in the Spanish population.Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity.Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells.Immunopathogenesis of inflammatory bowel diseaseCrucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis.The light and dark sides of intestinal intraepithelial lymphocytesIL-33 Aggravates DSS-Induced Acute Colitis in Mouse Colon Lamina Propria by Enhancing Th2 Cell ResponsesAssociation between Polymorphisms in Antioxidant Genes and Inflammatory Bowel DiseaseIL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitisNovel insights on the effect of nicotine in a murine colitis model.Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora.Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis.Type 3 Muscarinic Receptors Contribute to Clearance of Citrobacter rodentium.Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?Inflammatory bowel disease: progress and current concepts of etiopathogenesis.Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis.Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.Inflammatory bowel disease: pathogenesis.Mechanisms of the regulation of the intestinal Na+/H+ exchanger NHE3Animal models of IBD: linkage to human disease.Lung transplantation: infection, inflammation, and the microbiome.What can we learn about biofilm/host interactions from the study of inflammatory bowel disease.Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations.A role for interleukin-33 in T(H)2-polarized intestinal inflammation?Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells.The regulating function of heterotrimeric G proteins in the immune system.Interleukin-33 and inflammatory bowel diseases: lessons from human studiesSystematic review of the effectiveness of biological therapy for active moderate to severe ulcerative colitis.Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors.Regulation of antiapoptotic and cytoprotective pathways in colonic epithelial cells in ulcerative colitis.
P2860
Q24633510-A534B2C3-9873-4DBF-ADBF-2D43489A341FQ26852740-B9248792-921C-4C1D-BC18-932D408E15C8Q27691430-A52B6EB3-3823-408C-A5D2-C1F00469753EQ28242852-0A20B5A0-A91C-4C86-8F00-170EE1BE7A71Q29547727-C4DE8BBD-04DE-4DB0-B125-311894D3981FQ29615500-969E72B0-BFC0-4446-9482-031ADCD09803Q33309481-1295C4F3-94DF-472B-B30B-F617A9C93A4BQ33782512-517DB3FD-2009-4778-A0CA-2CFA629DEC7CQ34104200-143677E2-2444-45A2-B4C3-91FF8B0F1C0FQ34373760-D56F00DA-7832-4939-9EB0-2ECB71090D36Q34628470-430A0DAE-0812-44A0-92BE-88E51AD21A72Q34778713-01E243FC-77B6-48B2-B454-4E5395DE27B3Q35119562-C7ECC4BA-2454-4030-8CC4-4CEFFD4A3013Q35730495-C372AA1C-917E-42A5-B17B-7BA17AB882F4Q36239427-892D2081-1E58-4E21-A1A5-B39F10BF3FB6Q36303708-95207647-B39D-45F9-9D0F-3D07343249DEQ36497596-0E6B0CC2-E11A-49C8-B955-4BB28DB2C069Q36533450-DDD13181-EDE6-49E5-AEDC-50D31995D699Q36593729-C3DE7CE3-9DB8-4338-ACBA-EEA86125B84DQ36700662-8E3DAA31-0C74-415A-81BA-9BCAC6E4A180Q36765812-ABA63FBD-B244-4AB3-ACBD-88875E2CFDF0Q36804314-998F84A5-9D2B-412D-ACA6-FC67DCB3243EQ36986001-9491094B-ADE1-4712-A775-D1152C144B9EQ37226310-23FB4A59-993E-4F93-98AB-C42DBDA02C91Q37258771-AFC86056-2C37-4B8B-9D7C-B4999C55C215Q37454586-F0C20003-D62F-42DD-8B01-939C5818B16BQ37462304-98B75846-1FF3-4368-B6EC-D79DB4013A17Q37791260-2280878F-5DB5-4D57-B544-46298EE9BBDDQ37832677-07659EC0-F695-4B7F-B9BA-ED58D9B2F0A1Q37842621-F89EB4A1-124D-473F-B383-3F1F76CC11FDQ37847059-AF071164-8F09-4E4C-904F-48A425F978FAQ37863515-E6BB9BDD-9AE6-44B9-A6A9-8C59B6D591C7Q37879908-AE7236EE-EF1F-41AD-AA9A-F2AC7EEE1605Q37998396-419CCA52-9B95-47BE-B878-A64441A6F44EQ38096880-9BDB75F4-CF99-4532-8A74-8012A5F0A1F3Q38202097-36EFEDAA-0AB3-45BD-B84E-364177853BF4Q38222449-82642021-68B2-483F-AD5A-5DA951B87FE9Q38253468-E5843782-759B-4B1B-BBD7-F6534E70EB23Q38298369-C7C25065-3CA4-4AEC-B1C1-D1A2252C2FBEQ38619242-A8FE9D32-E84C-43AB-B320-6861D1E24AF6
P2860
Defects in mucosal immunity leading to ulcerative colitis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Defects in mucosal immunity leading to ulcerative colitis.
@ast
Defects in mucosal immunity leading to ulcerative colitis.
@en
Defects in mucosal immunity leading to ulcerative colitis.
@nl
type
label
Defects in mucosal immunity leading to ulcerative colitis.
@ast
Defects in mucosal immunity leading to ulcerative colitis.
@en
Defects in mucosal immunity leading to ulcerative colitis.
@nl
prefLabel
Defects in mucosal immunity leading to ulcerative colitis.
@ast
Defects in mucosal immunity leading to ulcerative colitis.
@en
Defects in mucosal immunity leading to ulcerative colitis.
@nl
P2860
P1476
Defects in mucosal immunity leading to ulcerative colitis.
@en
P2093
Loren C Karp
Stephan R Targan
P2860
P304
P356
10.1111/J.0105-2896.2005.00286.X
P577
2005-08-01T00:00:00Z